"People living with obesity need treatment options that meet them where they are and for many, a once-daily pill that can be taken with no food or water restrictions can offer them greater flexibility in how they approach their treatment," said Deborah Horn , DO, Director of the Center for Obesity Medicine at McGovern Medical School at UTHealth Houston
For semaglutide, this means beginning at 0.25 mg weekly for four weeks
A spokesperson for Eli Lilly, the manufacturer of Mounjaro and Zepbound (tirzepatide), told The Post that the medications include robust, FDA-approved warnings. Patient safety is Lillys top priority, and we actively monitor, evaluate and report safety information for all our medicines, they said in a statement
Here, their focus settles on glutathione one of the gentlest ingredients to help lift pigment and balance skin tone
FDA approvals for weight loss indications have increased use and patient demand for easy-to-use formulations is increasing interest in oral GLP-1 alternatives in addition to the most popular injectables
However, pharmacological agents are beginning to achieve comparable levels of effectiveness
